— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor ...
Please provide your email address to receive an email when new articles are posted on . The expanded label includes administration as adductor canal block and sciatic nerve block in the popliteal ...
The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Studies highlight the clinical effectiveness of EXPAREL for total knee arthroplasty and long-term pain management with ioveraº for patients ...
Pacira Biosciences PCRX announced that the FDA has accepted for review its supplemental new drug application (sNDA) for Exparel. The sNDA seeks to expand Exparel’s label to include a single-dose ...
Ultrasound-guided peripheral nerve blocks have a higher success rate compared to nerve stimulation or other methods, according to a study conducted by the Department of Anesthesiology at Johns Hopkins ...
Please provide your email address to receive an email when new articles are posted on . A mid-calf nerve block may lead to early rehabilitation after total ankle replacement. The mid-calf nerve block ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results